CS CGP - HUTCHMED (China) Company Director

HMDCF Stock  USD 3.66  0.00  0.00%   

Insider

CS CGP is Company Director of HUTCHMED Limited
Age 70
Phone852 2128 1188
Webhttps://www.hutch-med.com

HUTCHMED (China) Management Efficiency

The company has return on total asset (ROA) of (0.1932) % which means that it has lost $0.1932 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2472) %, meaning that it generated substantial loss on money invested by shareholders. HUTCHMED (China)'s management efficiency ratios could be used to measure how well HUTCHMED (China) manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Carnie LindeAspen Pharmacare Holdings
54
Karin SamuschDermapharm Holding SE
N/A
Mauricio ChristovamHypera SA
N/A
Brian LooHaw Par
N/A
Stavros NicolaouAspen Pharmacare Holdings
58
Trevor ZimanAspen Pharmacare Holdings
51
Sean CapazorioAspen Pharmacare Holdings
56
Britta HambergerDermapharm Holding SE
N/A
Hlio SegourasHypera SA
N/A
Luiz ClavisHypera SA
N/A
Kun ChiewHaw Par
N/A
Edward KremerCuraleaf Holdings
51
James ShorrisCuraleaf Holdings
61
Adalmario CoutoHypera SA
N/A
Lorraine HillAspen Pharmacare Holdings
59
Peter JDCuraleaf Holdings
55
BCom BComAspen Pharmacare Holdings
61
Matthew DarinCuraleaf Holdings
N/A
Tang ChowHaw Par
N/A
Tang LeeHaw Par
N/A
Zizipho MmangoAspen Pharmacare Holdings
38
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchison China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2110 people. HUTCHMED Limited [HMDCF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

HUTCHMED Limited Leadership Team

Elected by the shareholders, the HUTCHMED (China)'s board of directors comprises two types of representatives: HUTCHMED (China) inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUTCHMED. The board's role is to monitor HUTCHMED (China)'s management team and ensure that shareholders' interests are well served. HUTCHMED (China)'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUTCHMED (China)'s outside directors are responsible for providing unbiased perspectives on the board's policies.
Selina Zhang, VP HR
Kin MBA, Sr Devel
Karen Atkin, Ex COO
CA BEc, CFO Director
CS CGP, Company Director
Charles Nixon, Group Counsel
Qingmei Wang, Sr Alliances
Hong Chen, VP China
ACGI BSc, Ex Chairman
Weiguo BSc, Chief CEO

HUTCHMED Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is HUTCHMED (China) a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in HUTCHMED Pink Sheet

HUTCHMED (China) financial ratios help investors to determine whether HUTCHMED Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HUTCHMED with respect to the benefits of owning HUTCHMED (China) security.